Power Law company profile

Ascendis Pharma

Biotech & Life Sciences · Gentofte Municipality, Denmark · Founded 2007 · IPO 2015 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$14B

Market cap · Apr/2026

Revenue

$751M

Latest reported FY

Investors

8 investors on Ascendis Pharma's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

Gilde Healthcare

Sofinnova Partners

Series B+ 6 investors entered at this stage

Venrock

RA Capital Management

OrbiMed

Vivo Capital

Rock Springs Capital

Sofinnova Investments

Global footprint

Where Ascendis Pharma has talent and traffic

AI talent share

0.2% of workforce is AI talent
(3 of 1,370 staff)

Core AI10.07%

Other AI20.15%

Non-AI workforce1,36799.78%

Web traffic by country

24K monthly visits
across markets

🇺🇸 United States51.7%

🇩🇰 Denmark11.3%

🇬🇧 United Kingdom5.8%

🇩🇪 Germany5.8%

🇵🇹 Portugal5.4%

Top 5 markets shown

Patent intelligence

$275M patent portfolio · 112 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$275M

2.0% of market cap · comparable to top peer Reata Pharmaceuticals ($354M)

112 active patent families

Where Ascendis Pharma innovates Medicinal chemistryProdrugPharmaceutical SubstancesPharmaceutical drugPharmaceutical formulation

Above peer median on Legal, Market

Quality vs same-sector peers

Ascendis Pharma on the five Patsnap quality dimensions

Ascendis Pharma in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Ascendis Pharma concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Ascendis Pharma and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Ascendis Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo